Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Poly(ethylene Glycol Succinate) | Poly(ethylene Glycol Succinate). Group: Polymers. CAS No. 25569-53-3. Product ID: butanedioic acid; ethane-1,2-diol. Molecular formula: 180.16g/mol. Mole weight: C6H12O6. C(CC(=O)O)C(=O)O.C(CO)O. InChI=1S/C4H6O4. C2H6O2/c5-3(6)1-2-4(7)8; 3-1-2-4/h1-2H2, (H, 5, 6)(H, 7, 8); 3-4H, 1-2H2. VJVOPINBJQWMNY-UHFFFAOYSA-N. |  |
| Poly(ethylene glycol) disuccinimidyl succinate | SS-PEG. CAS No. 78274-32-5. Product ID: 7-00058. Molecular formula: PEG-[OCO(CH2)2CO2C4H4NO2]2. Mole weight: Mw 2,000. Purity: >98%. |  |
| Poly(ethylene glycol) disuccinimidyl succinate | SS-PEG. CAS No. 78274-32-5. Product ID: 7-00059. Molecular formula: PEG-[OCO(CH2)2CO2C4H4NO2]2. Mole weight: Mw 5,000. Purity: >98%. | |
| 4arm-PEG10K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 10000. | |
| 4arm-PEG20K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 20000. | |
| 4arm-PEG40K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 40000. | |
| 8arm-PEG10K-Succinimidyl Succinate | 8arm-PEG10K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG15K-Succinimidyl Succinate | 8arm-PEG15K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-Succinimidyl Succinate | 8arm-PEG20K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| Poly(ethylene succinate) | The polymer product is a hydrophobic material that is insoluble in water or other polar solvents. Uses: Our hydrophobic polymers are used as coatings, adhesives, fibers, films and engineering plastics. furthermore, they are widely used as biomedical polymers for vascular grafts, implants and ophthalmic applications. Group: Hydrophobic polymerspolymers. Alternative Names: Ethylene glycol succinate. CAS No. 25569-53-3. Product ID: butanedioic acid; ethane-1,2-diol. Molecular formula: average Mw 10,000. Mole weight: (OCH2CH2O2CCH2CH2CO)n. OCCO.OC(=O)CCC(O)=O. 1S/C4H6O4.C2H6O2/c5-3(6)1-2-4(7)8; 3-1-2-4/h1-2H2, (H, 5, 6)(H, 7, 8); 3-4H, 1-2H2. VJVOPINBJQWMNY-UHFFFAOYSA-N. | |
| Polyethylene succinate | Polyethylene succinate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Butanedioicacid,polymerwith1,2-ethanediol;ETHYLENE GLYCOL SUCCINATE POLYESTER;POLY(ETHYLENE SUCCINATE);POLY(ETHYLENE GLYCOL SUCCINATE);SUCCINATE ETHYLENE GLYCOL POLYESTER;ETHYLENE GLYCOL SUCCINATE, FOR GC;Poly(ethylene Glycol Succinate) [Liquid Phase for. Product Category: Polymer/Macromolecule. CAS No. 25569-53-3. Molecular formula: C6H10O5. Mole weight: 10000. Purity: MP 88-90deg. Density: 1.08. Product ID: ACM25569533. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Tocofersolan | Tocofersolan. Uses: Designed for use in research and industrial production. Additional or Alternative Names: DL-A-TOCOPHEROL POLYETHYLENE GLYCOL SUCCINATE;DL-ALPHA-TOCOPHEROL POLYETHYLENE GLYCOL SUCCINATE;d-alpha-tocopheryl polyethylene glycol succinate;alpha-(4-((3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2h-1-benzopyran-6-yl)oxy)-1,4-dioxobutanol poly(ethylene glycol) succinate;tocofersolan;tocopherosolan;2-ethanediyl). alpha.-[4-[[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzoPoly(oxy-1;4-dioxobutyl)-omega-hydroxy--trimethyltridecyl)-2h-1-benzopyran-6-yl)oxy)-. Appearance: Clear, colorless solid. CAS No. 9002-96-4. Molecular formula: C39H66O8. Mole weight: 662.942. Purity: 0.96. IUPACName: Vitamin E-TPGS. Density: 1.01g/cm³. Product ID: ACM9002964. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4, 7, 10, 13, 16, 19, 22, 25, 32, 35, 38, 41, 44, 47, 50, 53-Hexadecaoxa-28, 29-dithiahexapentacontanedioic acid di-N-succinimidyl ester | 4, 7, 10, 13, 16, 19, 22, 25, 32, 35, 38, 41, 44, 47, 50, 53-Hexadecaoxa-28, 29-dithiahexapentacontanedioic acid di-N-succinimidyl ester. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 947601-98-1. Product ID: (2,5-dioxopyrrolidin-1-yl) 3- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [3- (2, 5-dioxopyrrolidin-1-yl) oxy-3-oxopropoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethyldisulfanyl] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] propanoate. Molecular formula: 1109.3g/mol. Mole weight: C46H80N2O24S2. C1CC (= O) N (C1= O) OC (= O) CCOCCO CCOCCOCCOCCOCCOCCOCCSSCCOCCOCCOCCOCC OCCOCCOCCOCCC (= O) ON2C (= O) CCC2= O. InChI= 1S / C46H80N2O24S2 / c49-41-1-2-42 (50) 47 (41) 71-45 (53) 5-7-55-9-11-57-13-15-59-17-19-61-21-2 3-63-25-27-65-29-31-67-33-35-69-37-39 -73-74-40-38-70-36-34-68-32-30-66-28- 26-64-24-22-62-20-18-60-16-14-58-12-1 0-56-8-6-46 (54) 72-48-43 (51) 3-4-44 (48) 52 / h1-40H2. CIAGMHUFXZNZOO-UHFFFAOYSA-N. | |
| 4arm-PEG10K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester, 4arm-PEG-SCM. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Carboxymethyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Glutaramide. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 10000. | |
| 4arm-PEG20K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Carboxymethyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Glutaramide. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 20000. | |
| 4arm-PEG40K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 40000. | |
| 4arm-PEG5K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 5000. | |
| 8arm-PEG10K-Succinimidyl Glutarate | 8arm-PEG10K-Succinimidyl Glutarate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG15K-Succinimidyl Glutarate | 8arm-PEG15K-Succinimidyl Glutarate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG20K-Succinimidyl Glutarate | 8arm-PEG20K-Succinimidyl Glutarate. Group: Poly(ethylene glycol) and poly(ethylene oxide). | |
| 8arm-PEG40K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 40000. | |
| 8arm-PEG40K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 40000. | |
| Fluorescein poly(ethylene glycol) succinimidyl | FITC-PEG-NHS. Product ID: 7-00173. Mole weight: Mw 5,000. | |
| FMOC-PEG5K-Succinimide Butanoate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| Methoxypolyethylene glycol 5,000 acetic acid N-succinimidyl ester | Methoxypolyethylene glycol 5,000 acetic acid N-succinimidyl ester. Group: Poly(ethylene glycol) and poly(ethylene oxide)polymerization initiators. CAS No. 92451-01-9. Product ID: (2,5-dioxopyrrolidin-1-yl) 2-(2-hydroxyethoxy)acetate; 2-methoxyethanol. Molecular formula: 293.27g/mol. Mole weight: C11H19NO8. COCCO.C1CC(=O)N(C1=O)OC(=O)COCCO. InChI=1S/C8H11NO6. C3H8O2/c10-3-4-14-5-8 (13)15-9-6 (11)1-2-7 (9)12; 1-5-3-2-4/h10H, 1-5H2; 4H, 2-3H2, 1H3. NYXRHTOXAYVBMV-UHFFFAOYSA-N. | |
| mPEG10K-Succinimidyl Carboxymethyl Ester | Methoxy PEG NHS Ester (SCM PEG). Amine reactive PEG towards the amino groups of lysine(s) on proteins or other biologics; reaction occurs at room temperature in <1hr at pH 7-8. Stable linker between PEG and NHS ester. Uses: S may include: bioconjugation, drug delivery, peg hydrogel, crosslinker, and surface functionalization. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 10000. | |
| mPEG20K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 20000. | |
| mPEG30K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 30000. | |
| mPEG40K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: mPEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 40000. | |
| Multi-arm PEG-succinimidyl glutarate | four-arm branched poly(ethylene glycol) derivatives with succinimidyl glutarate function for conjugation. CAS No. Product ID: 7-00238. Molecular formula: Mole weight: Mw 10,000 Da. | |
| Multi-arm PEG-succinimidyl glutarate | six-arm branched poly(ethylene glycol) derivatives with succinimidyl glutarate function for conjugation. CAS No. Product ID: 7-00239. Molecular formula: Mole weight: Mw 10,000 Da. Properties: | |
| O-[2-(3-Succinylamino)ethyl]-O'-methyl-polyethylene glycol | O-[2-(3-Succinylamino)ethyl]-O'-methyl-polyethylene glycol. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 92450-99-2. | |
| O-[2-(Biotinyl-amino)ethyl]-O'-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol | O-[2-(Biotinyl-amino)ethyl]-O'-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 948595-10-6. | |
| O-[2-(Boc-amino)ethyl]-O'-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 3,000 | O-[2-(Boc-amino)ethyl]-O'-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 3,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 778648-12-7. | |
| O-[2-(Boc-amino)ethyl]-O'-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 5000 | O-[2-(Boc-amino)ethyl]-O'-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 5000. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 778648-12-7. | |
| O-[2-(Fmoc-amino)-ethyl]-O'-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 3000 | O-[2-(Fmoc-amino)-ethyl]-O'-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 3000. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 488085-18-3. Product ID: (2,5-dioxopyrrolidin-1-yl) 3- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- (9H-fluoren-9-ylmethoxycarbonylamino) ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] propanoate. Molecular formula: 937g/mol. Mole weight: C46H68N2O18. C1CC (= O) N (C1= O) OC (= O) CCOCCO CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC ( = O) OCC2C3= CC= CC= C3C4= CC= CC= C 24. InChI= 1S / C46H68N2O18 / c49-43-9-10-44 (50) 48 (43) 66-45 (51) 11-13-53-15-17-55-19-21-57-23-25-59-2 7-29-61-31-33-63-35-36-64-34-32-62-30 -28-60-26-24-58-22-20-56-18-16-54-14- 12-47-46 (52) 65-37-42-40-7-3-1-5-38 (40) 39-6-2-4-8-41 (39) 42 / h1-8, 42H, 9-37H2, (H, 47, 52). HQKUPHFWWTZASE-UHFFFAOYSA-N. | |
| O-Methyl-O'-succinylpolyethylene glycol 2'000 | O-Methyl-O'-succinylpolyethylene glycol 2'000. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 31961-02-1. | |
| O-Methyl-O'-succinylpolyethylene glycol 5'000 | O-Methyl-O'-succinylpolyethylene glycol 5'000. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 31961-02-1. | |
| O-[N- (6-Maleimidohexanoyl)aminoethyl]-O'-[3- (N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 3,000 | O-[N- (6-Maleimidohexanoyl)aminoethyl]-O'-[3- (N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 3,000. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 948595-09-3. Product ID: (2,5-dioxopyrrolidin-1-yl) 3- [2- [2- [6- (2, 5-dioxopyrrol-1-yl) hexanoylamino] ethoxy] ethoxy] propanoate. Molecular formula: 467.5g/mol. Mole weight: C21H29N3O9. C1CC (=O)N (C1=O)OC (=O)CCOCCOCCNC (=O)CCCCCN2C (=O)C=CC2=O. InChI=1S/C21H29N3O9/c25-16 (4-2-1-3-11-23-17 (26)5-6-18 (23)27)22-10-13-32-15-14-31-12-9-21 (30)33-24-19 (28)7-8-20 (24)29/h5-6H, 1-4, 7-15H2, (H, 22, 25). RKGUGSULMVQEIX-UHFFFAOYSA-N. | |
| O-[(N-Succinimidyl)succinyl-aminoethyl]-O'-methylpolyethylene glycol | O-[(N-Succinimidyl)succinyl-aminoethyl]-O'-methylpolyethylene glycol. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 92451-00-8. | |
| O-[(N-Succinimidyl)succinyl-aminoethyl]-O'-methylpolyethylene glycol 2'000 | O-[(N-Succinimidyl)succinyl-aminoethyl]-O'-methylpolyethylene glycol 2'000. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 92451-00-8. | |
| O,O'-Bis[2-(N-Succinimidyl-succinylamino)ethyl]polyethylene glycol | O,O'-Bis[2-(N-Succinimidyl-succinylamino)ethyl]polyethylene glycol. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 186020-53-1. | |
| Poly(ethylene oxide)4-armsuccinimid& | Poly(ethylene oxide)4-armsuccinimid&. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: POLY(ETHYLENE OXIDE)4-ARMSUCCINIMID&; peo-4 arm-sg terminated; Poly(ethylene oxide), 4-arm, succinimidyl glutarate terminated average Mn 10,000 by GPC. CAS No. 154467-38-6. 96%. | |
| Poly(ethylene oxide), 4-arm, succinimidyl succinate terminated | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| Succinimidyl Glutaramide-PEG5K-Succinimidyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| Succinimidyl Succinamide-PEG5K-Succinimidyl Succinamide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
Our database is helping our users find suppliers everyday.
